What ultrasound examination is recommended for assessing a palpable inguinal lymph node?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ultrasound with Doppler and US-Guided Fine-Needle Aspiration for Groin Lymph Nodes

For palpable inguinal lymph nodes, perform ultrasound with Doppler followed by US-guided fine-needle aspiration biopsy (FNAB) of any suspicious nodes—this combination achieves 93% sensitivity and 100% specificity for detecting metastases. 1

Recommended Ultrasound Technique

Initial Ultrasound Assessment with Doppler

Perform grayscale ultrasound combined with color/power Doppler to evaluate inguinal lymph nodes. Look for these specific suspicious features:

  • Absent or effaced fatty hilum (echogenic center)
  • Cortical thickness ≥4 mm
  • Circular/rounded shape (long-to-short axis ratio ≥2 or short-to-long axis ratio >0.75)
  • Irregular contour or borders
  • Peripheral vascularization pattern on Doppler (rather than central hilar flow)
  • Short-axis diameter >8-10 mm

1, 2, 3

Performance Characteristics

US with Doppler alone demonstrates:

  • Sensitivity: 76-87%
  • Specificity: 86-91%
  • Negative predictive value: 87-94%

1, 3, 4

Critical Next Step: US-Guided FNAB

When ultrasound identifies suspicious features, immediately proceed to US-guided FNAB of the largest or most abnormal lymph node in each groin. This dramatically improves diagnostic accuracy:

  • Sensitivity increases to 80-93%
  • Specificity increases to 100%
  • Positive predictive value: 93-100%
  • Negative predictive value: 100%

1

Clinical Decision Algorithm

For Palpable Nodes:

  1. Perform US with Doppler of both groins
  2. If suspicious features present → US-guided FNAB
  3. If FNAB positive → proceed to complete lymphadenectomy or definitive treatment (not sentinel node biopsy)
  4. If FNAB negative but high clinical suspicion → consider US-guided lymph node excision 5, 6

For Non-Palpable Nodes:

US with Doppler still valuable for detecting occult disease, with similar diagnostic criteria. However, negative imaging does not exclude micrometastases—sentinel lymph node biopsy remains necessary for pathologic staging in intermediate-to-high risk tumors. 7

Important Caveats

The main limitation is undersampling of micrometastases with FNAB—the technique excels at detecting macrometastases but may miss microscopic disease. 1 This is why:

  • Negative FNAB in high-risk patients still requires surgical staging
  • US-guided FNAB is most valuable for confirming suspected metastases to guide treatment planning
  • When metastases are confirmed by FNAB, sentinel node biopsy is contraindicated—proceed directly to complete lymphadenectomy or radiation therapy 1

Key Measurements to Document

For standardized reporting, measure and document:

  • Cortical thickness (most predictive when ≥2.5 mm; sensitivity 90%, specificity 78%) 2
  • Short-axis diameter (suspicious when >8.4 mm; sensitivity 64%, specificity 91%) 2
  • Cortex-to-medulla ratio (suspicious when >1.2; sensitivity 70%, specificity 92%) 2
  • Vascularization pattern (peripheral vs. central hilar)
  • Presence/absence of fatty hilum

The combination of short-axis diameter and cortex-to-medulla ratio provides the highest accuracy (sensitivity 89%, specificity 82%). 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.